Contrast induced nephropathy natural history, complications and prognosis
Contrast Induced Nephropathy Microchapters |
Differentiating Contrast induced nephropathy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Contrast induced nephropathy natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Contrast induced nephropathy natural history, complications and prognosis |
FDA on Contrast induced nephropathy natural history, complications and prognosis |
CDC on Contrast induced nephropathy natural history, complications and prognosis |
Contrast induced nephropathy natural history, complications and prognosis in the news |
Blogs on Contrast induced nephropathy natural history, complications and prognosis |
Directions to Hospitals Treating Contrast induced nephropathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
The reported incidence of CIN varies widely depending on the presence or absence of risk factors, CIN associated with a significantly higher risk of in-hospital and 1-year mortality, even in patients who do not need dialysis.
Natural history, Complications and Prognosis
There is a complicated relationship between CIN, comorbidity, and mortality. Most patients who develop CIN do not die from renal failure rather than from either a preexisting nonrenal complication, or a procedural complication.
Nonrenal complications include procedural cardiac complications (eg, Q-wave MI, coronary artery bypass graft [CABG], hypotension, shock), vascular complications (eg, femoral bleeding, hematoma, pseudoaneurysm, stroke), and systemic complications (eg, acute respiratory distress syndrome [ARDS], pulmonary embolism).